Literature DB >> 35177889

The Role of Diagnostic Imaging in Macular Telangiectasia Type 2.

Brett Zerbinopoulos1,2, Elina Goman-Baskin1,2, Paul B Greenberg1,3, Richard Bryan1,3, Claire Messina1,2.   

Abstract

While uncommon with subtle findings, macular telangiectasia type 2 can be diagnosed with careful retinal examination and selective use of diagnostic imaging.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID： 35177889      PMCID： PMC8843004          DOI： 10.12788/fp.0200

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


  12 in total

Review 1.  The Diagnosis and Management of Macular Telangiectasia.

Authors:  Panos G Christakis; Howard F Fine; Henry E Wiley
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-03-01       Impact factor: 1.300

2.  LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.

Authors:  Tjebo F C Heeren; Diána Kitka; Daniela Florea; Traci E Clemons; Emily Y Chew; Alan C Bird; Daniel Pauleikhoff; Peter Charbel Issa; Frank G Holz; Tunde Peto
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

3.  VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2.

Authors:  Peter Charbel Issa; Tjebo F C Heeren; Elke H Kupitz; Frank G Holz; Tos T J M Berendschot
Journal:  Retina       Date:  2016-03       Impact factor: 4.256

4.  Idiopathic juxtafoveolar retinal telangiectasis.

Authors:  J D Gass; R T Oyakawa
Journal:  Arch Ophthalmol       Date:  1982-05

Review 5.  Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2.

Authors:  Luiz Roisman; Philip J Rosenfeld
Journal:  Dev Ophthalmol       Date:  2016-03-15

6.  Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.

Authors:  Emily Y Chew; Traci E Clemons; Glenn J Jaffe; Charles A Johnson; Sina Farsiu; Eleonora M Lad; Robyn Guymer; Philip Rosenfeld; Jean-Pierre Hubschman; Ian Constable; Henry Wiley; Lawrence J Singerman; Mark Gillies; Grant Comer; Barbara Blodi; Dean Eliott; Jiong Yan; Alan Bird; Martin Friedlander
Journal:  Ophthalmology       Date:  2018-10-04       Impact factor: 12.079

Review 7.  Management of Idiopathic Macular Telangiectasia Type 2.

Authors:  Alireza Khodabande; Ramak Roohipoor; Javad Zamani; Masoud Mirghorbani; Hamidreza Zolfaghari; Shahab Karami; Bobeck S Modjtahedi
Journal:  Ophthalmol Ther       Date:  2019-02-20

8.  Right-angled vessels in macular telangiectasia type 2.

Authors:  Simone Tzaridis; Tjebo Heeren; Clarissa Mai; Sarah Thiele; Frank G Holz; Peter Charbel Issa; Philipp Herrmann
Journal:  Br J Ophthalmol       Date:  2019-02-26       Impact factor: 4.638

Review 9.  When is macular edema not macular edema? An update on macular telangiectasia type 2.

Authors:  Lihteh Wu
Journal:  Taiwan J Ophthalmol       Date:  2015-11-14

10.  Overlap between telangiectasia and photoreceptor loss increases with progression of macular telangiectasia type 2.

Authors:  Paul S Micevych; Hee Eun Lee; Amani A Fawzi
Journal:  PLoS One       Date:  2019-10-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.